BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 11711353)

  • 1. Does capsular incision at radical retropubic prostatectomy affect disease-free survival in otherwise organ-confined prostate cancer?
    Barocas DA; Han M; Epstein JI; Chan DY; Trock BJ; Walsh PC; Partin AW
    Urology; 2001 Nov; 58(5):746-51. PubMed ID: 11711353
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The significance of positive surgical margin in areas of capsular incision in otherwise organ confined disease at radical prostatectomy.
    Chuang AY; Nielsen ME; Hernandez DJ; Walsh PC; Epstein JI
    J Urol; 2007 Oct; 178(4 Pt 1):1306-10. PubMed ID: 17698141
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prostate-specific antigen after anatomic radical retropubic prostatectomy. Patterns of recurrence and cancer control.
    Pound CR; Partin AW; Epstein JI; Walsh PC
    Urol Clin North Am; 1997 May; 24(2):395-406. PubMed ID: 9126237
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Residual prostatic tumour in the surgical bed following radical prostatectomy in organ-confined prostate cancer: possible prognostic significance.
    Valotto C; Falconieri G; Pizzolitto S; Cerruto MA; Brondani G; De Gobbi A; Zattoni F
    Arch Ital Urol Androl; 2011 Jun; 83(2):78-82. PubMed ID: 21826879
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical and pathologic outcome after radical prostatectomy for prostate cancer patients with a preoperative Gleason sum of 8 to 10.
    Bastian PJ; Gonzalgo ML; Aronson WJ; Terris MK; Kane CJ; Amling CL; Presti JC; Mangold LA; Humphreys E; Epstein JI; Partin AW; Freedland SJ
    Cancer; 2006 Sep; 107(6):1265-72. PubMed ID: 16900523
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term biochemical disease-free and cancer-specific survival following anatomic radical retropubic prostatectomy. The 15-year Johns Hopkins experience.
    Han M; Partin AW; Pound CR; Epstein JI; Walsh PC
    Urol Clin North Am; 2001 Aug; 28(3):555-65. PubMed ID: 11590814
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term cancer control of radical prostatectomy in men younger than 50 years of age: update 2003.
    Khan MA; Han M; Partin AW; Epstein JI; Walsh PC
    Urology; 2003 Jul; 62(1):86-91; discussion 91-2. PubMed ID: 12837428
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of positive surgical margins on prostate-specific antigen failure after radical prostatectomy in adjuvant treatment-naïve patients.
    Ploussard G; Agamy MA; Alenda O; Allory Y; Mouracade P; Vordos D; Hoznek A; Abbou CC; de la Taille A; Salomon L
    BJU Int; 2011 Jun; 107(11):1748-54. PubMed ID: 20883488
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cancer control and quality of life following anatomical radical retropubic prostatectomy: results at 10 years.
    Walsh PC; Partin AW; Epstein JI
    J Urol; 1994 Nov; 152(5 Pt 2):1831-6. PubMed ID: 7523730
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Prognostic implications of positive margins in radical prostatectomy specimens].
    Ojea Calvo A; González Piñeiro A; Domínguez Freire F; Alonso Rodrigo A; Rodríguez Iglesias B; Benavente Delgado J
    Actas Urol Esp; 2005; 29(7):641-56. PubMed ID: 16180314
    [TBL] [Abstract][Full Text] [Related]  

  • 11. What are the factors associated with short prostate specific antigen doubling time after radical prostatectomy? A report from the SEARCH database group.
    Teeter AE; Bañez LL; Presti JC; Aronson WJ; Terris MK; Kane CJ; Amling CL; Freedland SJ;
    J Urol; 2008 Nov; 180(5):1980-4; discussion 1985. PubMed ID: 18801519
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Seminal vesicle involvement after radical prostatectomy: predicting risk factors for progression.
    Salomon L; Anastasiadis AG; Johnson CW; McKiernan JM; Goluboff ET; Abbou CC; Olsson CA; Benson MC
    Urology; 2003 Aug; 62(2):304-9. PubMed ID: 12893340
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Implications of greater short-term PSA recurrence with laparoscopic as compared to retropubic radical prostatectomy for Japanese clinically localized prostate carcinomas.
    Akita H; Okamura T; Ando R; Nagata D; Naruyama H; Yamada Y; Naiki T; Yasui T; Tozawa K; Kohri K
    Asian Pac J Cancer Prev; 2011; 12(11):2959-61. PubMed ID: 22393971
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early prostate-specific antigen relapse after radical retropubic prostatectomy: prediction on the basis of preoperative and postoperative tumor characteristics.
    Graefen M; Noldus J; Pichlmeier U; Haese A; Hammerer P; Fernandez S; Conrad S; Henke R; Huland E; Huland H
    Eur Urol; 1999; 36(1):21-30. PubMed ID: 10364651
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ten-year survival after radical prostatectomy: specimen Gleason score is the predictor in organ-confined prostate cancer.
    Bianco FJ; Wood DP; Cher ML; Powell IJ; Souza JW; Pontes JE
    Clin Prostate Cancer; 2003 Mar; 1(4):242-7. PubMed ID: 15040883
    [TBL] [Abstract][Full Text] [Related]  

  • 16. After radical retropubic prostatectomy 'insignificant' prostate cancer has a risk of progression similar to low-risk 'significant' cancer.
    Sengupta S; Blute ML; Bagniewski SM; Inman B; Leibovich BC; Slezak JM; Myers RP; Zincke H
    BJU Int; 2008 Jan; 101(2):170-4. PubMed ID: 18173824
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is preoperative serum prostate-specific antigen level significantly related to clinical recurrence after radical retropubic prostatectomy for localized prostate cancer?
    Haukaas SA; Halvorsen OJ; Daehlin L; Hostmark J; Akslen LA
    BJU Int; 2006 Jan; 97(1):51-5. PubMed ID: 16336328
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stage T1-2 prostate cancer: a multivariate analysis of factors affecting biochemical and clinical failures after radical prostatectomy.
    Kupelian PA; Katcher J; Levin HS; Klein EA
    Int J Radiat Oncol Biol Phys; 1997 Mar; 37(5):1043-52. PubMed ID: 9169811
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of radical prostatectomy in patients with prostate cancer of high Gleason score.
    Tefilli MV; Gheiler EL; Tiguert R; Banerjee M; Sakr W; Grignon D; Wood DP; Pontes JE
    Prostate; 1999 Apr; 39(1):60-6. PubMed ID: 10221268
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Location of positive surgical margins after retropubic, perineal, and laparoscopic radical prostatectomy for organ-confined prostate cancer.
    Salomon L; Anastasiadis AG; Levrel O; Katz R; Saint F; de la Taille A; Cicco A; Vordos D; Hoznek A; Chopin D; Abbou CC
    Urology; 2003 Feb; 61(2):386-90. PubMed ID: 12597953
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.